Eledon Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead pro…

Biotechnology
US, Irvine [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Eledon Pharmaceuticals, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of ELDN's Analysis
CIK: 1404281 CUSIP: 28617K101 ISIN: US28617K1016 LEI: - UEI: -
Secondary Listings
ELDN has no secondary listings inside our databases.